Advertisement Frutarom gets new patent for FenuLife - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Frutarom gets new patent for FenuLife

Frutarom has received a patent EP 2026763 B1, to treat heartburn and gastroesophageal reflux disease (GERD) with FenuLife.

The company claims FenuLife is a completely natural fenugreek fiber that can act as a prophylactic treatment for heartburn and reflux symptoms.

In addition to the prophylactic function, the patent also claims that products using FenuLife can serve to reduce temporary acid reflux symptoms due to pregnancy.

In a study the efficacy of FenuLife in diminishing heartburn severity for subjects with frequent occurrences was scientifically proven.

The study results suggested that it was similarly effective as the positive control, the commonly used OTC antacid Ranitidine.